Connection
Joel Marrs to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Joel Marrs has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.624 |
|
|
|
-
Marrs JC, Haidar CE. ASHP Statement on Pharmacist Prescribing of Statins. Am J Health Syst Pharm. 2022 11 22; 79(23):2182-2184.
Score: 0.640
-
Marrs JC, Kostoff MD. Discontinuation of Statins: What Are the Risks? Curr Atheroscler Rep. 2016 Jul; 18(7):41.
Score: 0.411
-
Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9.
Score: 0.233
-
Anderson SL, Marrs JC, Chachas CR, Cichon BS, Cizmic AD, Calderon BB, Vlasimsky TB. Evaluation of a Pharmacist-Led Intervention to Improve Statin Use in Persons with Diabetes. J Manag Care Spec Pharm. 2020 Jul; 26(7):910-917.
Score: 0.136
-
Zupec JF, Marrs JC, Saseen JJ. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Ann Pharmacother. 2016 Jan; 50(1):17-21.
Score: 0.097
-
Marrs JC. Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease. Am J Manag Care. 2011 Dec; 17 Suppl 15:S403-11.
Score: 0.075
-
Wiggins BS, Dixon D, Bellone J, Gasbarro N, Marrs JC, Tran R. Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894.
Score: 0.032